SCHEMBL31316729

SCHEMBL31316729

CN(C)C(=O)c1ccccc1-n1ccc(N)n1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KEAP1 Q14145 1/20 0.37
HCRTR1 O43613 5/20 0.36
HCRTR2 O43614 5/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
CAPN1 P07384 1/20 0.34
MYC P01106 2/20 0.34
NR4A1 P22736 1/20 0.34
KDM4E B2RXH2 2/20 0.34
GLA P06280 1/20 0.34
ALDH1A1 P00352 3/20 0.33
TNKS O95271 1/20 0.33
TGFBR1 P36897 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31316765 0.78 F2 (0.44) MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL31316889 0.71 PMM2 (0.44) MEN1KMT2AKEAP1
SCHEMBL5958591 0.71 ADORA3 (0.44) KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL29571936 0.71 ADORA3 (0.44) KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL188296 0.69 MEN1 (0.65) MEN1KMT2ASMN1; SMN2KEAP1KDM4E
SCHEMBL30598338 0.68 SMN1; SMN2 (0.55) MEN1KMT2ASMN1; SMN2KEAP1KDM4E
SCHEMBL538290 0.68 SMN1; SMN2 (0.55) MEN1KMT2ASMN1; SMN2KEAP1KDM4E
SCHEMBL403403 0.67 MEN1 (0.49) MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL15639447 0.67 MGLL (0.37) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL29571794 0.67 MGLL (0.37) MEN1KMT2ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743453-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION Pretzel Therapeutics, Inc. (US) 2026-05-20 EP disclosed
WO-2025015178-A1 MODULATORS OF MITOCHONDRIAL DNA REPLICATION PRETZEL THERAPEUTICS, INC. (US) 2025-01-16 WO disclosed